Platelet Transfusion Events
| Disease . | Autologous PBSC (n = 355) . | Allogeneic BM (n = 283) . | ||||
|---|---|---|---|---|---|---|
| Eval . | Median . | Range . | Eval . | Median . | Range . | |
| Breast cancer | 144 | 4.0 | 1.0-40.0 | 1 | 12.0 | 12.0-12.0 |
| Chronic myeloid leukemia | 7 | 10.0 | 0.0-41.0 | 86 | 11.0 | 3.0-54.0 |
| Acute myeloid leukemia | 9 | 8.0 | 3.0-29.0 | 76 | 14.5 | 1.0-53.0 |
| Acute lymphoid leukemia | 2 | 10.5 | 10.0-11.0 | 29 | 14.0 | 3.0-53.0 |
| Myelodysplastic syndrome | 34 | 11.5 | 3.0-60.0 | |||
| Aplastic anemia | 9 | 11.0 | 6.0-33.0 | |||
| Congenital diseases | 6 | 13.0 | 6.0-22.0 | |||
| Non-Hodgkin's lymphoma | 74 | 5.0 | 1.0-51.0 | 17 | 9.0 | 1.0-51.0 |
| Hodgkin's disease | 24 | 4.5 | 2.0-17.0 | 3 | 9.0 | 3.0-50.0 |
| Multiple myeloma | 72 | 2.0 | 0.0-26.0 | 15 | 9.0 | 2.0-22.0 |
| Other solid tumors | 21 | 6.0 | 0.0-25.0 | 3 | 9.0 | 7.0-11.0 |
| Other leukemias | 2 | 9.5 | 4.0-15.0 | 4 | 5.5 | 3.0-12.0 |
| Disease . | Autologous PBSC (n = 355) . | Allogeneic BM (n = 283) . | ||||
|---|---|---|---|---|---|---|
| Eval . | Median . | Range . | Eval . | Median . | Range . | |
| Breast cancer | 144 | 4.0 | 1.0-40.0 | 1 | 12.0 | 12.0-12.0 |
| Chronic myeloid leukemia | 7 | 10.0 | 0.0-41.0 | 86 | 11.0 | 3.0-54.0 |
| Acute myeloid leukemia | 9 | 8.0 | 3.0-29.0 | 76 | 14.5 | 1.0-53.0 |
| Acute lymphoid leukemia | 2 | 10.5 | 10.0-11.0 | 29 | 14.0 | 3.0-53.0 |
| Myelodysplastic syndrome | 34 | 11.5 | 3.0-60.0 | |||
| Aplastic anemia | 9 | 11.0 | 6.0-33.0 | |||
| Congenital diseases | 6 | 13.0 | 6.0-22.0 | |||
| Non-Hodgkin's lymphoma | 74 | 5.0 | 1.0-51.0 | 17 | 9.0 | 1.0-51.0 |
| Hodgkin's disease | 24 | 4.5 | 2.0-17.0 | 3 | 9.0 | 3.0-50.0 |
| Multiple myeloma | 72 | 2.0 | 0.0-26.0 | 15 | 9.0 | 2.0-22.0 |
| Other solid tumors | 21 | 6.0 | 0.0-25.0 | 3 | 9.0 | 7.0-11.0 |
| Other leukemias | 2 | 9.5 | 4.0-15.0 | 4 | 5.5 | 3.0-12.0 |
Abbreviation: Eval, number of evaluable patients.